Publikation:

Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?

Vorschaubild

Dateien

Kraemer_0-408546.pdf
Kraemer_0-408546.pdfGröße: 2.28 MBDownloads: 369

Datum

2017

Autor:innen

Krämer, Julia
Tenberge, Jan-Gerd
Kleiter, Ingo
Gaissmaier, Wolfgang
Ruck, Tobias
Heesen, Christoph
Meuth, Sven G.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

URI (zitierfähiger Link)
http://nbn-resolving.de/urn:nbn:de:bsz:352-0-408546
DOI (zitierfähiger Link)
https://doi.org/10.1371/journal.pone.0174858
ArXiv-ID

Internationale Patentnummer

Link zur Lizenz

CC BY 4.0

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Open Access Gold

Sammlungen

Psychologie: Publikationen
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

PLOS ONE. 2017, 12(4), e0174858. eISSN 1932-6203. Available under: doi: 10.1371/journal.pone.0174858

Zusammenfassung

Progressive multifocal leukoencephalopathy (PML) is one of the major risks of natalizumab therapy. Despite introduction of the currently employed PML risk stratification algorithm, the incidence of natalizumab-associated PML cases is not decreasing.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
150 Psychologie

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690KRÄMER, Julia, Jan-Gerd TENBERGE, Ingo KLEITER, Wolfgang GAISSMAIER, Tobias RUCK, Christoph HEESEN, Sven G. MEUTH, 2017. Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?. In: PLOS ONE. 2017, 12(4), e0174858. eISSN 1932-6203. Available under: doi: 10.1371/journal.pone.0174858
BibTex
@article{Kramer2017progr-39148,
  year={2017},
  doi={10.1371/journal.pone.0174858},
  title={Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?},
  number={4},
  volume={12},
  journal={PLOS ONE},
  author={Krämer, Julia and Tenberge, Jan-Gerd and Kleiter, Ingo and Gaissmaier, Wolfgang and Ruck, Tobias and Heesen, Christoph and Meuth, Sven G.},
  note={Article Number: e0174858}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39148">
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/39148/1/Kraemer_0-408546.pdf"/>
    <dc:creator>Meuth, Sven G.</dc:creator>
    <dc:contributor>Kleiter, Ingo</dc:contributor>
    <dc:contributor>Heesen, Christoph</dc:contributor>
    <dcterms:abstract xml:lang="eng">Progressive multifocal leukoencephalopathy (PML) is one of the major risks of natalizumab therapy. Despite introduction of the currently employed PML risk stratification algorithm, the incidence of natalizumab-associated PML cases is not decreasing.</dcterms:abstract>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:creator>Tenberge, Jan-Gerd</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-07T09:26:48Z</dc:date>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/39148"/>
    <dc:contributor>Gaissmaier, Wolfgang</dc:contributor>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/39148/1/Kraemer_0-408546.pdf"/>
    <dc:contributor>Krämer, Julia</dc:contributor>
    <dcterms:issued>2017</dcterms:issued>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-06-07T09:26:48Z</dcterms:available>
    <dc:creator>Kleiter, Ingo</dc:creator>
    <dc:creator>Gaissmaier, Wolfgang</dc:creator>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/>
    <dc:contributor>Tenberge, Jan-Gerd</dc:contributor>
    <dc:creator>Heesen, Christoph</dc:creator>
    <dc:creator>Krämer, Julia</dc:creator>
    <dcterms:title>Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?</dcterms:title>
    <dc:creator>Ruck, Tobias</dc:creator>
    <dc:contributor>Ruck, Tobias</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:contributor>Meuth, Sven G.</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen